Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists

被引：6
作者：
Neumiller, Joshua J. [1 ]
Shubrook, Jay H. [2 ]
Manley, Tom [3 ]
Alicic, Radica Z. [4 ,5 ,6 ]
Tuttle, Katherine R. [4 ,7 ,8 ]
机构：
[1] Washington State Univ, Coll Pharm & Pharmaceut Sci, Spokane, WA 99202 USA
[2] Touro Univ, Primary Care Dept, Vallejo, CA USA
[3] Natl Kidney Fdn, New York, NY USA
[4] Providence Hlth Care, Providence Med Res Ctr, Spokane, WA USA
[5] Univ Washington, Div Med, Spokane, WA USA
[6] Univ Washington, Div Med, Seattle, WA 98195 USA
[7] Univ Washington, Div Nephrol, Kidney Res Inst, Spokane, WA USA
[8] Univ Washington, Div Nephrol, Kidney Res Inst, Seattle, WA USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2022年 / 79卷 / 01期
关键词：
diabetic kidney disease; kidney outcomes; multidisciplinary care; pharmacist intervention; SGLT2; inhibitor; INTERVENTIONS; MANAGEMENT; MORTALITY; CARE;
D O I：
10.1093/ajhp/zxab271
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：E65 / E70
页数：6
相关论文
共 39 条
  • [1] Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
    Afkarian, Maryam
    Sachs, Michael C.
    Kestenbaum, Bryan
    Hirsch, Irl B.
    Tuttle, Katherine R.
    Hinnmelfarb, Jonathan
    de Boer, Ian H.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02): : 302 - 308
  • [2] 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021
    不详
    [J]. DIABETES CARE, 2021, 44 : S15 - S33
  • [3] Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease
    Anderegg, Maxwell D.
    Gums, Tyler H.
    Uribe, Liz
    MacLaughlin, Eric J.
    Hoehns, James
    Bazaldua, Oralia V.
    Ives, Timothy J.
    Hahn, David L.
    Coffey, Christopher S.
    Carter, Barry L.
    [J]. PHARMACOTHERAPY, 2018, 38 (03): : 309 - 318
  • [4] Introduction
    不详
    [J]. DIABETES CARE, 2017, 40 : S1 - S130
  • [5] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) : 2219 - 2229
  • [6] CDC, 2021, CHRON KIDN DIS US
  • [7] Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
    Cea Soriano, Lucia
    Johansson, Saga
    Stefansson, Bergur
    Garcia Rodriguez, Luis A.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [8] Centers for Disease Control and Prevention, 2020, National diabetes statistics report, 2020 | CDC
  • [9] Centers for Medicare and Medicaid Services, MED THER MAN
  • [10] Centers for Medicare & Medicaid Services, KIDN CAR CHOIC KCC M
1234